Who is sponsoring NCT04951011?

NCT04951011 is sponsored by Sohag University.

What drugs are being tested in NCT04951011?

Interventions in NCT04951011: Serum beta HCG.

What condition does NCT04951011 study?

NCT04951011 studies Woman With Tubal Ectopic Pregnancy.

Is NCT04951011 still recruiting?

NCT04951011 is currently status unknown. Last updated 6 July 2021.

Last reviewed 2021-07-06 · How we verify

NCT04951011

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Different Treatment Options for Tubal Ectopic Pregnancy:- A Systmatic Review

Status unknown Last updated 6 July 2021

What this trial tests

trial testing Serum beta HCG in Woman With Tubal Ectopic Pregnancy in 50 participants. Status unknown.

Timeline

1 July 2021

Primary endpoint
1 January 2022

1 January 2022

Quick facts

Lead sponsor	Sohag University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 July 2021
Primary completion	1 January 2022
Estimated completion	1 January 2022
Sites	1 location across Egypt

Drugs / interventions tested

Serum beta HCG

Conditions studied

Woman With Tubal Ectopic Pregnancy — all drugs for Woman With Tubal Ectopic Pregnancy →

Sponsor

Sohag University

Who can join

Adults 15 to 40, female only, with Woman With Tubal Ectopic Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ectopic pregnancy is an early pregnancy complication in which a fertilized ovum implant outside the uterine cavity. Implantation may occur anywhere along the reproductive tract with the most common implantation site being the fallopian tube. The incidence of ectopic pregnancy is 1% of pregnant women, and may seriously compromise women's health and future fertility. Currently, ectopic pregnancy can be often diagnosed before the woman's condition has deteriorated, which has altered the former clinical picture of a lifethreatening disease into a more benign condition in frequently asymptomatic women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04951011 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 6 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04951011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing